
Join to View Full Profile
200 Lothrop StreetUniversity Drive CPittsburgh, PA 15213
Phone+1 412-360-6000
Dr. Mayr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Florian Mayr is an Internal Medicine specialist with a subspecialty in Critical Care Medicine, based in Pittsburgh, PA. He completed his medical education at the University of Vienna Faculty of Medicine in 2002 and further pursued an MPH at the University of Pittsburgh. Dr. Mayr's training includes a residency in Internal Medicine and a fellowship in Critical Care Medicine at UPMC Medical Education. He holds positions as an Attending Physician at the Veterans Affairs Pittsburgh Healthcare System since 2015 and as an Associate Professor in Critical Care Medicine since 2023. His research interests primarily revolve around sepsis and clinical research, with numerous published works on sepsis, COVID-19, and other critical care topics. He is also involved in clinical trials focusing on novel experimental COVID-19 therapies.
Education & Training
- UPMC Medical Education/Presbyterian Shadyside HospitalFellowship, Critical Care Medicine, 2014 - 2016
- UPMC Medical EducationResidency, Internal Medicine, 2011 - 2014
- UPMC Medical EducationPost-Doctoral Fellowship, 2007 - 2010
- University of Vienna Faculty of MedicineClass of 2002
- University of PittsburghMPH
Certifications & Licensure
- PA State Medical License 2014 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
Clinical Trials
- Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15
Roles: Contact
Publications & Presentations
PubMed
- Design and methods of an adaptive trial to test comparative effectiveness of readmission reduction approaches following infection and sepsis hospitalizations (ACCOMPLI...Kristin Mayes, Victor B Talisa, Adelina Malito, Florian B Mayr, Kelly Williams
Contemporary Clinical Trials Communications. 2025-08-01 - Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial.Lennie Derde, Anthony C Gordon, Paul R Mouncey, Farah Al-Beidh, Kathryn M Rowan
Thorax. 2025-07-15 - 5 citationsHeterogeneity in the Effect of Early Goal-Directed Therapy for Septic Shock: A Secondary Analysis of Two Multicenter International Trials.Faraaz Ali Shah, Victor B Talisa, Chung-Chou H Chang, Sofia Triantafyllou, Lu Tang
Critical Care Medicine. 2025-01-01
Press Mentions
- Study Reveals Racial Disparities in COVID-19 Therapy but Not DeathOctober 26th, 2022
- Differences in Clinical Treatment, Outcomes by Race Among Veterans Hospitalized with CovidOctober 26th, 2022
- Black Veterans Received Worse COVID-19 Care Than White Veterans, Pitt Study FindsOctober 25th, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: